Published online August 1, 2006
PEDIATRICS Vol. 118 No. 2 August 2006, pp. 586-593 (doi:10.1542/peds.2006-0120)
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, R. S.
Right arrow Articles by Nguyen, H. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, R. S.
Right arrow Articles by Nguyen, H. T.
Related Collections
Right arrow Genitourinary Tract
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Antenatal Hydronephrosis as a Predictor of Postnatal Outcome: A Meta-analysis

Richard S. Lee, MDa, Marc Cendron, MDa, Daniel D. Kinnamon, MSb and Hiep T. Nguyen, MDa

a Department of Urology, Children's Hospital Boston, Boston, Massachusetts
b Department of Pediatrics, Division of Pediatric Clinical Research, University of Miami Miller School of Medicine, Miami, Florida


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
OBJECTIVE.Antenatal hydronephrosis is diagnosed in 1% to 5% of all pregnancies; however, the antenatal and postnatal management of hydronephrosis varies widely. No previous studies define the risk of postnatal pathology in infants with antenatal hydronephrosis. Our objective was to review the current literature to determine whether the degree of antenatal hydronephrosis and related antenatal ultrasound findings are associated with postnatal outcome.

METHODS. We searched Medline (1966–2005), Embase (1991–2004), and the Cochrane Library databases for articles on antenatal hydronephrosis. We required studies to have subjects selected on the basis of documented measurements of antenatal hydronephrosis and followed to a postnatal diagnosis. We excluded case reports, review articles, and editorials. Two independent investigators extracted data.

RESULTS. We screened 1645 citations, of which 17 studies met inclusion criteria. We created a data set of 1308 subjects. The risk of any postnatal pathology per degree of antenatal hydronephrosis was 11.9% for mild, 45.1% for moderate, and 88.3% for severe. There was a significant increase in risk per increasing degree of hydronephrosis. The risk of vesicoureteral reflux was similar for all degrees of antenatal hydronephrosis.

CONCLUSIONS. The findings of this meta-analysis can potentially be used for prenatal counseling and may alter current postnatal management of children with antenatal hydronephrosis. Overall, children with any degree of antenatal hydronephrosis are at greater risk of postnatal pathology as compared with the normal population. Moderate and severe antenatal hydronephrosis have a significant risk of postnatal pathology, indicating that comprehensive postnatal diagnostic management should be performed. Mild antenatal hydronephrosis may carry a risk for postnatal pathology, but additional prospective studies are needed to determine the optimal management of these children. A well-defined prospective analysis is needed to further define the risk of pathology and the appropriate management protocols.

Key Words: hydronephrosis • renal • kidney disease • prenatal • outcome

Abbreviations: ANH—antenatal hydronephrosis • VCUG—voiding cystourethrogram • APD—anterior posterior diameter • UPJ—ureteropelvic junction obstruction • VUR—vesicoureteral reflux • CI—confidence interval

Antenatal hydronephrosis (ANH) affects ~1% to 5% of all pregnancies and is one of the most common birth defects.1–4 However, the reported clinical relevance of varying degrees of ANH is unclear.4–13 Although the use of prenatal ultrasound as a screening tool for birth defects has not been shown to improve perinatal outcome, more patients are undergoing prenatal counseling for the discovery of ANH.13 Patients diagnosed with ANH on routine ultrasound often undergo extensive prenatal imaging that may include serial ultrasound and MRI. In addition, patients may undergo postnatal examinations that may include a variable combination of serial renal ultrasound, voiding cystourethrogram (VCUG), diuretic renogram, intravenous pyelogram, and MRI urogram. Although current prenatal testing is mostly noninvasive, much of the postnatal assessment is invasive and exposes the child to radiation or anesthesia that may be unnecessary.

The efficacy and social health care costs of routine prenatal ultrasound as a screening tool for potential postnatal health risks remains controversial.14–16 The diagnosis of ANH may cause significant parental anxiety and physician uncertainty with regard to prenatal and postnatal management.8,16–20 Many variations in the definition and management of ANH exist in the literature and clinical practice, including method and frequency of in utero testing, radiographic documentation, classification, or postnatal management.8,17–21 To date, there are no comprehensive prospective studies that determine the risk of pathology with varying degrees of ANH or those aspects of ANH that predict postnatal diagnosis or kidney outcome. To address these questions, we performed a meta-analysis of all published case series of ANH to determine whether or not the degree of ANH is associated with the risk of postnatal pathology.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Meta-analysis Search Strategy
In collaboration with a research librarian, we searched Medline (1966–2004), Embase (1991–2004), and the Cochrane Library databases to identify pertinent articles in English. We combined 10 terms for hydronephrosis (hydronephrosis, pelviectasis, pelvocaliectasis, pyelectasis, hydroureteronephrosis, renal pelvic dilation, anterior posterior diameter, oligohydramnios, calyceal dilation, and ureteral dilation) with 6 terms for prenatal (prenatal, newborn, antenatal, fetal, natural history, and ultrasound). We simultaneously searched reference lists of research articles, reviews, and texts to ensure that we acquired all of the relevant articles. We did not contact authors for original data and did not consider unpublished reports.

Inclusion and Exclusion Criteria
We reviewed all of the articles obtained from the literature search and only included studies that met the following ANH criteria: (1) diagnosed in utero by ultrasound; (2) reported anterior posterior diameter (APD) or a specific APD range; and (3) reported postnatal diagnosis of hydronephrosis. We included women of all races/ethnicities and ages. We excluded studies that (1) were case reports, editorials, or review articles, (2) lacked reported APD, (3) did not report postnatal follow-up or diagnosis, (4) only reported on patients with multisystem congenital malformations, coexisting chromosomal abnormality, history of fetal intervention, or fetal termination, or (5) selected subjects on the basis of postnatal diagnosis.

Data Extraction
Two investigators (R.S.L. and H.T.N.) independently screened the abstracts and the articles considered for inclusion and performed independent data extraction. Investigator consensus (R.S.L., H.T.N., D.D.K., and M.C.) reconciled any differences in data acquisition.

The degree of hydronephrosis classified by APD characterized the ANH data across the studies. Using the current literature on APD measurements, we developed 3 major classifications of ANH: mild ANH, moderate ANH, and severe ANH (Table 1). To accommodate reported APD ranges that crossed between major classifications, we defined 2 additional ANH classifications, mild-moderate ANH and moderate-severe ANH (Table 1).


View this table:
[in this window]
[in a new window]
  		TABLE 1 Classification of ANH by APD

 
In addition to APD measurements, we attempted to extract other ultrasound findings, such as renal calyceal dilation, hydroureteronephrosis, renal echogenicity, renal parenchymal thinning, bladder dilation, posterior urethral dilation, and amniotic fluid level. We also attempted to extract the gestational age at diagnosis, gender, laterality, and presence or absence of bilateral hydronephrosis.

We classified the postnatal diagnoses into 6 categories: (1) normal or transient hydronephrosis (resolved without intervention); (2) ureteropelvic junction obstruction (UPJ); (3) vesicoureteral reflux (VUR); (4) urethral obstruction, such as posterior urethral valves or urethral atresia; (5) ureteral obstruction, such as ureterocele, ectopic ureterocele, and obstructing megaureter; and (6) others (multicystic dysplastic kidney, prune belly syndrome, hydrometrocolpos, and bladder agenesis).

We considered patients with bilateral ANH as 1 subject. When possible, we based our analysis on the renal unit with the worse degree of ANH and its corresponding outcome. We excluded patients that were lost to follow-up, excluded by the original author in each study, or had indeterminate prenatal or postnatal data. We considered a patient as lost to follow-up if there was no postnatal follow-up or the postnatal diagnosis was unavailable. Indeterminate patients did not have extractable APD data or did not have a prenatal diagnosis of hydronephrosis.

Statistical Analysis
Logistic regression was used to estimate the risk of any postnatal pathology for different degrees of ANH. Robust SEs based on generalized estimating equations with a working independence correlation structure were used to account for correlated outcomes within each study. Similar methods were used to estimate the risks of specific pathologic diagnoses for different degrees of ANH. Tests for trend in the risks of postnatal pathologies with increasing degree of ANH were conducted using equally spaced scores in these logistic regression models.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 CONCLUSIONS
 REFERENCES
 
We screened 1645 citations and found 17 case series that met inclusion and exclusion criteria. A total of 1678 subjects of 104572 subjects screened (1.6% prevalence) had ANH (Table 2). The studies analyzed did not use the same ultrasound criteria or prenatal and postnatal imaging protocols to define, detect, and follow ANH (Table 3). We were unable to cluster the studies by prenatal or postnatal diagnostic protocols. Prenatal imaging protocols varied widely with regard to the timing of the initial and follow-up prenatal ultrasound and the number of follow-up prenatal ultrasounds. As for postnatal diagnostic imaging, 15 of 17 studies performed a renal ultrasound sometime within the first 7 days after birth. The use of further diagnostic studies, such as VCUG or functional studies (diuretic renogram or intravenous pyelogram), varied significantly between studies, and 2 studies did not document their postnatal protocol. The length of follow-up for each study was not available. We stratified the subjects using the ANH categories defined in Table 1 regardless of the classification of ANH by the study.


View this table:
[in this window]
[in a new window]
  		TABLE 2 Disposition of Subjects in Included Studies

 

View this table:
[in this window]
[in a new window]
  		TABLE 3 Antenatal and Postnatal Management Protocols for Patients Included in Each Study

 
Of the 1678 patients with ANH, 246 were lost to follow-up, and 124 were excluded because of indeterminate prenatal data, leaving 1308 patients for analysis. Sixty-five patients had bilateral disease.22–25 Data for each renal unit in these 65 patients was not obtainable but was reported by the authors as a single subject.

Table 4 shows the number of patients in each category of ANH in each of the 17 studies and the percentage of patients in each study with any postnatal pathology. Only 4 studies had patients in each of the 3 major categories of ANH.9,24,26,27 Four studies had patients in mild and moderate-severe categories.4,23,28,29 One study solely contributed patients to the mild-moderate ANH classification.30 In Table 4, postnatal pathology is grouped into those who had any pathology versus those who had no pathology or transient postnatal hydronephrosis. Taking all of the patients with any degree of ANH, 36% had pathology discovered during postnatal management.


View this table:
[in this window]
[in a new window]
  		TABLE 4 Subject Breakdown by Degree of ANH and Postnatal Pathology Among Included Studies

 
We determined the risk of any pathology (UPJ, VUR, posterior urethral valves, ureteral obstruction, and other) for each degree of ANH (Table 5). The overall risk of any pathology was 11.9% (95% confidence interval [CI]: 4.5–28.0) for mild ANH, 45.1% (95% CI: 25.3–66.6) for moderate ANH, and 88.3% (95% CI: 53.7–98.0) for severe ANH. The risk of postnatal pathology rose significantly with increasing degree of ANH (P < .001).


View this table:
[in this window]
[in a new window]
  		TABLE 5 Risk of Pathology by Degree of ANH

 
The risks and 95% CIs for specific pathologic diagnoses for each degree of ANH are also shown in Table 5. For all of the pathologic diagnosis other than VUR, there was a significant increase in risk with increasing degree of ANH. There was no evidence of a trend in the risk of VUR across different degrees of ANH (P = .10).

We attempted to extract other antenatal ultrasound findings, such as renal calyceal dilation, hydroureteronephrosis, renal echogenicity, renal parenchymal thinning, bladder dilation, posterior urethral dilation, amniotic fluid level, gestational age at diagnosis, gender, laterality, and presence or absence of bilateral hydronephrosisas, and correlate these to outcome. However, because of the variability in reporting and lack of data, we were unable to perform an appropriate analysis.


   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
CONCLUSIONS
 REFERENCES
 
The precision and value of antenatal ultrasound as a screening modality remains controversial.10–14,31,32 Our analysis of 1308 subjects with varying degrees of ANH suggests that the risk of a pathologic postnatal outcome of ANH may be quantified by the measurement of APD. For instance, the overall risk of VUR in the ANH population (8.6%) is quantifiably higher than the general population incidence (1%) indicating that a prenatal diagnosis of ANH may confer a significant increased risk for postnatal pathology.33

As expected, our meta-analysis confirms that severe ANH carries a significant risk of a postnatal pathologic outcome (88.3%). The primary debate centers on the postnatal outcome of mild or moderate ANH. We demonstrate a significant risk of pathology in both of these categories (11.9% and 45.1%, respectively), which potentially indicates that more thorough postnatal diagnostic management should be considered when confronted with a child with this condition.

Clinicians often use other aspects of the prenatal ultrasound, such as renal calyceal dilation, renal echogenicity, renal parenchymal thinning, hydroureteronephrosis, bladder dilation, posterior urethral dilation, amniotic fluid level, gender, gestational age, and laterality to help provide an assessment of risk for postnatal pathology and to plan postnatal management. Although these additional ultrasound parameters are reported as potential predictors of postnatal pathology, the articles published to date have not provided the appropriate detail to determine what additional prenatal or postnatal tests should be conducted.

For instance, there are only 3 studies among those considered that reported results on amniotic fluid levels.8,25,34 Of these studies, only 2 had subjects with oligohydramnios.8,34 Because of the sparseness of the data and the fact that all patients with oligohydramnios had postnatal pathology, the same techniques used for estimating CIs for the risk by degree of ANH could not be applied in the setting of oligohydramnios. Similar lapses in the data are seen for the other parameters considered. Undoubtably, these additional parameters play a crucial role in determining the risk of postnatal pathology. Further rigorous prospective analysis is needed to determine the prognostic value of these prenatal ultrasound findings.

In addition, there is a lack of conformity in the definition of ANH. A survey study of European pediatric urologists and nephrologists demonstrates a lack of consensus in defining ANH and in management.16 The literature we reviewed demonstrated no conformity in the definition of ANH. We were unable to apply current grading standards, such as the Society of Fetal Urology grading of hydronephrosis, to the reported studies or analysis, because the studies did not report all of the required data for this grading system. As a result, it was necessary to create a rigorous but arbitrary definition of ANH based on the 1 factor most consistently reported: APD. Nevertheless, based on this review, we do not feel that the grading of ANH will be based solely on APD.

Likewise, there are major variations in the method of prenatal screening and postnatal diagnostic follow-up. Our analysis demonstrated significant variability in the timing of the initial and follow-up ultrasound and in the number of follow-up prenatal ultrasounds (Table 3). Reports demonstrate that the degree of ANH can change in utero and that the amount of change may be a significant indicator of postnatal outcome.5,35–41 In addition, prenatal ultrasound performed in the third trimester as opposed to earlier in the pregnancy may be more predictive of postnatal outcome.5,26,37–43 However, because of the inconsistent reporting and variable prenatal protocols, we were unable to determine whether or not timing of prenatal ultrasound or serial ultrasound influenced outcome or provided additional prognostic information. The incongruity of the screening protocols reviewed may introduce substantial heterogeneity into the study and challenges the accuracy of APD as the sole indicator of postnatal outcome.

Similarly, standardized protocols for postnatal management of ANH and independent standardized outcome measures of ANH do not exist. Table 3 demonstrates a significant variation in the postnatal diagnostic testing protocol in each study, which may bias the outcome toward one diagnosis over another. Most importantly, the definition by each protocol of significant postnatal hydronephrosis varies, which is a requirement in many protocols for further postnatal diagnostic investigation. Patients who are classified as normal or transient after the initial postnatal ultrasound and do not undergo further diagnostic investigation may actually have postnatal pathology. Many studies show that a negative postnatal ultrasound is not a reliable indicator or predictor for the exclusion of VUR.44–47 The variability in postnatal protocols may have introduced a selectivity bias toward a diagnosis of normal/transient as opposed to VUR, particularly if the patients are not adequately studied or followed in the postnatal period. Similarly, some postnatal protocols are selective in their performance of a functional test to determine whether the postnatal hydronephrosis is secondary to UPJ obstruction. The ability to definitively diagnose UPJ obstruction is debated on many levels, including the timing and method of testing, to the functional definition of obstruction.48–51 These 2 variations in postnatal protocols may result in underdiagnosing pathology and may, therefore, have underestimated the risks of pathology downward. At the same time the postnatal diagnosis may not be the most important outcome measure, because some of the pathologic diagnoses may resolve without intervention or damage to the health of the child. Rather, the need for surgical intervention or the onset of renal damage may be more appropriate outcome measures. However, these outcome measures have their own inherent subjective biases.

In addition, the decision to place a child on prophylactic antibiotics because of VUR risk before postnatal diagnostic imaging is controversial. The articles considered in this meta-analysis did not address this controversy. To date, there were no large comprehensive prospective studies that determine the risk of VUR with varying degrees of ANH. Numerous small series demonstrated that children with ANH have an increased risk of VUR as compared with the general population.48,52,53 However, although the data were limited, children with ANH and VUR seemingly have a more benign course with a higher resolution rate of VUR as compared with children discovered to have VUR after a febrile infection.54–56 The decision to place a child with ANH on prophylactic antibiotics remains controversial, and we were unable to clarify this controversy through this analysis.

We could not estimate the health care burden of screening patients with varying degrees of ANH. The articles published to date do not address the cost-effectiveness of serial prenatal ultrasound or extensive postnatal diagnostic evaluations and its relationship to postnatal outcome for different degrees of ANH. Further prospective work in this area is clearly needed. Ideally, a multicenter prospective study with strict prenatal and postnatal protocols would be needed to define the prognostic ability of ANH. These studies need to determine which parameters of a prenatal ultrasound are predictive, the timing and number of prenatal ultrasounds needed, the requisite postnatal diagnostic imaging protocol, and the overall cost-effectiveness of the investigation.

Regardless, our analysis demonstrates a significant increased risk of postnatal pathology for any grade of ANH as compared with the normal population. In addition, when categorizing ANH by a measurable parameter, APD, a significant increase in the risk for all pathologies exists with each increasing grade of ANH, except for VUR. Our analysis provides realistic estimates of risk for each degree of ANH that may be of value in directing the prenatal and postnatal management of these patients.

Despite the issues discussed earlier, this analysis improves our ability to counsel families by providing them with realistic estimates of postnatal pathology, which may help decrease parental anxiety about ANH. This analysis was unable to determine whether the diagnosis of ANH or associated findings of ANH would lead to poor child or kidney-specific postnatal or long-term outcome. In addition, we were unable to determine whether more antenatal imaging was helpful. The study was unable to provide further insight into these aspects of prenatal counseling. Although no consensus for prenatal and postnatal follow-up exists, on discovery of ANH we recommend that during the prenatal period patients be followed by a center that specializes in maternal fetal medicine and prenatal imaging and undergo multidisciplinary prenatal counseling. Children with bilateral severe ANH or a solitary kidney with any grade of ANH should undergo a postnatal ultrasound before discharge from the hospital. Children with all other grades of ANH should undergo a postnatal ultrasound within the first month of life. Children with persistent moderate to severe ANH should undergo a VCUG and a functional study as indicated. Children with mild ANH that persists postnatally or children with resolved ANH should be considered for further diagnostic imaging on a case-by-case basis until appropriate guidelines have been determined by a rigorous prospective study.


   CONCLUSIONS
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
REFERENCES
 
Children with any degree of ANH are at greater risk of postnatal pathology as compared with the normal population. Moderate and severe ANH have a considerable risk of pathology, indicating that comprehensive postnatal diagnostic management should be performed. Mild ANH may carry a risk for postnatal pathology, but further prospective studies are needed to determine the optimal management of these children. To further define the risk of pathology and the appropriate management protocols for different degrees of ANH, a well-defined prospective analysis of the relationship between the parameters of prenatal ultrasound needs to be performed.


   ACKNOWLEDGMENTS
 
We thank Alison Clap for her assistance with the literature search and Dr David Wypij for his assistance with study design and statistics. We also thank Drs Stuart Bauer, Joseph Borer, Bartley Cilento, David Diamond, Carlos Estrada, Craig Peters, and Alan Retik for their insightful comments, guidance, and suggestions.


   FOOTNOTES
 
Accepted Mar 8, 2006.

Address correspondence to Richard S. Lee, MD, Children's Hospital Boston, Department of Urology, 300 Longwood Ave, Hunn-390, Boston, MA 02115. E-mail: richard.lee{at}childrens.harvard.edu

The authors have indicated they have no financial relationships relevant to this article to disclose.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 

  1. Blyth B, Snyder HM, Duckett JW. Antenatal diagnosis and subsequent management of hydronephrosis. J Urol. 1993;149 :693 –698[Web of Science][Medline]
  2. Gunn TR, Mora JD, Pease P. Antenatal diagnosis of urinary tract abnormalities by ultrasonography after 28 weeks' gestation: incidence and outcome. Am J Obstet Gynecol. 1995;172 :479 –486[CrossRef][Web of Science][Medline]
  3. Livera LN, Brookfield DS, Egginton JA, et al. Antenatal ultrasonography to detect fetal renal abnormalities: a prospective screening programme. BMJ. 1989;298 :1421 –1423[Abstract/Free Full Text]
  4. Sairam S, Al-Habib A, Sasson S, et al. Natural history of fetal hydronephrosis diagnosed on mid-trimester ultrasound. Ultrasound Obstet Gynecol. 2001;17 :191 –196[CrossRef][Web of Science][Medline]
  5. Ismaili K, Hall M, Donner C, et al. Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population. Am J Obstet Gynecol. 2003;188 :242 –246[CrossRef][Web of Science][Medline]
  6. Grandjean H, Larroque D, Levi S. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol. 1999;181 :446 –454[CrossRef][Web of Science][Medline]
  7. National Birth Defects Prevention Network. Birth Defects Surveillance Data from Selected States, 1997–2001. Atlanta, GA: National Birth Defects Prevention Network; 2004
  8. Adra AM, Mejides AA, Dennaoui MS, Beydoun SN. Fetal pyelectasis: is it always "physiologic"? Am J Obstet Gynecol. 1995;173 :1263 –1266[CrossRef][Web of Science][Medline]
  9. Kapadia H, Lidefelt KJ, Erasmie U, Pilo C. Antenatal renal pelvis dilatation emphasizing vesicoureteric reflux: two-year follow-up of minor postnatal dilatation. Acta Paediatr. 2004;93 :336 –339[CrossRef][Web of Science][Medline]
  10. Vanara F, Bergeretti F, Gaglioti P, Todros T. Economic evaluation of ultrasound screening options for structural fetal malformations. Ultrasound Obstet Gynecol. 2004;24 :633 –639[CrossRef][Web of Science][Medline]
  11. Roberts T, Henderson J, Mugford M, Bricker L, Neilson J, Garcia J. Antenatal ultrasound screening for fetal abnormalities: a systematic review of studies of cost and cost effectiveness. BJOG. 2002;109 :44 –56[Web of Science][Medline]
  12. Romano PS, Waitzman NJ. Can decision analysis help us decide whether ultrasound screening for fetal anomalies is worth it? Ann N Y Acad Sci. 1998;847 :154 –172[CrossRef][Web of Science][Medline]
  13. Ewigman BG, Crane JP, Frigoletto FD, LeFeuse ML, Bain RP, McNellis D. Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. N Engl J Med. 1993;329 :821 –827[Abstract/Free Full Text]
  14. Woolf SH. The accuracy and effectiveness of routine population screening with mammography, prostate-specific antigen, and prenatal ultrasound: a review of published scientific evidence. Int J Technol Assess Health Care. 2001;17 :275 –304[CrossRef][Web of Science][Medline]
  15. Harding LJ, Malone PS, Wellesley DG. Antenatal minimal hydronephrosis: is its follow-up an unnecessary cause of concern? Prenat Diagn. 1999;19 :701 –705[CrossRef][Web of Science][Medline]
  16. Ismaili K, Avni FE, Piepsz A, et al. Current management of infants with fetal renal pelvis dilation: a survey by French-speaking pediatric nephrologists and urologists. Pediatr Nephrol. 2004;19 :966 –971[Web of Science][Medline]
  17. Benacerraf BR, Mandell J, Estroff JA, Harlow BL, Frigoletto FD Jr. Fetal pyelectasis: a possible association with Down syndrome. Obstet Gynecol. 1990;76 :58 –60[Web of Science][Medline]
  18. Corteville JE, Dicke JM, Crane JP. Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted? Obstet Gynecol. 1992;79 :770 –772[Web of Science][Medline]
  19. Thompson MO, Thilaganathan B. Effect of routine screening for Down's syndrome on the significance of isolated fetal hydronephrosis. Br J Obstet Gynaecol. 1998;105 :860 –864[Web of Science][Medline]
  20. Chudleigh PM, Chitty LS, Pembrey M, Campbell S. The association of aneuploidy and mild fetal pyelectasis in an unselected population: the results of a multicenter study. Ultrasound Obstet Gynecol. 2001;17 :197 –202[CrossRef][Web of Science][Medline]
  21. Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr Radiol. 1993;23 :478 –480[CrossRef][Web of Science][Medline]
  22. Wilhelm C, Wieacker P, Quaas L, Schillinger H. Fetal urinary tract obstructions: prenatal diagnosis–prenatal and postnatal therapy. J Perinat Med. 1991;19 :357 –365[Web of Science][Medline]
  23. Lam BC, Wong SN, Yeung CY, Tang MH, Ghosh A. Outcome and management of babies with prenatal ultrasonographic renal abnormalities. Am J Perinatol. 1993;10 :263 –268[Web of Science][Medline]
  24. Fasolato V, Poloniato A, Bianchi C, et al. Feto-neonatal ultrasonography to detect renal abnormalities: evaluation of 1-year screening program. Am J Perinatol. 1998;15 :161 –164[Web of Science][Medline]
  25. Lepercq J, Beaudoin S, Bargy F. Outcome of 116 moderate renal pelvis dilatations at prenatal ultrasonography. Fetal Diagn Ther. 1998;13 :79 –81[CrossRef][Web of Science][Medline]
  26. Langer B, Simeoni U, Montoya Y, Casanova R, Schlaeder G. Antenatal diagnosis of upper urinary tract dilation by ultrasonography. Fetal Diagn Ther. 1996;11 :191 –198[Web of Science][Medline]
  27. Kent A, Cox D, Downey P, James SL. A study of mild fetal pyelectasia: outcome and proposed strategy of management. Prenat Diagn. 2000;20 :206 –209[CrossRef][Web of Science][Medline]
  28. Tam JC, Hodson EM, Choong KK, et al. Postnatal diagnosis and outcome of urinary tract abnormalities detected by antenatal ultrasound. Med J Aust. 1994;160 :633 –637[Web of Science][Medline]
  29. Arger PH, Coleman BG, Mintz MC, et al. Routine fetal genitourinary tract screening. Radiology. 1985;156 :485 –489[Abstract/Free Full Text]
  30. Ismaili K, Avni FE, Martin Wissing K, Hall M. Long-term clinical outcome of infants with mild and moderate fetal pyelectasis: validation of neonatal ultrasound as a screening tool to detect significant nephrouropathies. J Pediatr. 2004;144 :759 –765[Web of Science][Medline]
  31. Levi S. Ultrasound in prenatal diagnosis: polemics around routine ultrasound screening for second trimester fetal malformations. Prenat Diagn. 2002;22 :285 –295[CrossRef][Web of Science][Medline]
  32. Newnham JP, Doherty DA, Kendall GE, Zubrick SR, Landau LL, Stanley FJ. Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow-up of a randomised controlled trial. Lancet. 2004;364 :2038 –2044[CrossRef][Web of Science][Medline]
  33. Medical versus surgical treatment of primary vesicoureteral reflux: report of the International Reflux Study Committee. Pediatrics. 1981;67 :392 –400[Abstract/Free Full Text]
  34. Rosendahl H. Ultrasound screening for fetal urinary tract malformations: a prospective study in general population. Eur J Obstet Gynecol Reprod Biol. 1990;36 :27 –33[CrossRef][Web of Science][Medline]
  35. Anderson N, Clautice-Engle T, Allan R, Abbott G, Wells JE. Detection of obstructive uropathy in the fetus: predictive value of sonographic measurements of renal pelvic diameter at various gestational ages. AJR Am J Roentgenol. 1995;164 :719 –723[Abstract/Free Full Text]
  36. Bobrowski RA, Levin RB, Lauria MR, Treadwell MC, Gonik B, Bottoms SF. In utero progression of isolated renal pelvis dilation. Am J Perinatol. 1997;14 :423 –426[Web of Science][Medline]
  37. Siemens DR, Prouse KA, MacNeily AE, Sauerbrei EE. Antenatal hydronephrosis: thresholds of renal pelvic diameter to predict insignificant postnatal pelviectasis. Tech Urol. 1998;4 :198 –201[Medline]
  38. Aviram R, Pomeranz A, Sharony R, Beyth Y, Rathaus V, Tepper R. The increase of renal pelvis dilatation in the fetus and its significance. Ultrasound Obstet Gynecol. 2000;16 :60 –62[Web of Science][Medline]
  39. Feldman DM, DeCambre M, Kong E, et al. Evaluation and follow-up of fetal hydronephrosis. J Ultrasound Med. 2001;20 :1065 –1069[Abstract]
  40. Odibo AO, Marchiano D, Quinones JN, Riesch D, Egan JF, Macones GA. Mild pyelectasis: evaluating the relationship between gestational age and renal pelvic anterior-posterior diameter. Prenat Diagn. 2003;23 :824 –827[CrossRef][Web of Science][Medline]
  41. Cohen-Overbeek TE, Wijngaard-Boom P, Ursem NT, Hop WC, Wladimiroff JW, Wolffenbuttel KP. Mild renal pyelectasis in the second trimester: determination of cut-off levels for postnatal referral. Ultrasound Obstet Gynecol. 2005;25 :378 –383[CrossRef][Web of Science][Medline]
  42. Economou G, Egginton JA, Brookfield DS. The importance of late pregnancy scans for renal tract abnormalities. Prenat Diagn. 1994;14 :177 –180[Web of Science][Medline]
  43. Fugelseth D, Lindemann R, Sande HA, Refsum S, Nordshus T. Prenatal diagnosis of urinary tract anomalies. The value of two ultrasound examinations. Acta Obstet Gynecol Scand. 1994;73 :290 –293[Web of Science][Medline]
  44. Davey MS, Zerin JM, Reilly C, Ambrosius WT. Mild renal pelvic dilatation is not predictive of vesicoureteral reflux in children. Pediatr Radiol. 1997;27 :908 –911[CrossRef][Web of Science][Medline]
  45. Jaswon MS, Dibble L, Puri S, et al. Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child Fetal Neonatal Ed. 1999;80 :F135 –F138[Abstract/Free Full Text]
  46. Mahant S, Friedman J, MacArthur C. Renal ultrasound findings and vesicoureteral reflux in children hospitalised with urinary tract infection. Arch Dis Child. 2002;86 :419 –420[Abstract/Free Full Text]
  47. Aksu N, Yavascan O, Kangin M, et al. Postnatal management of infants with antenatally detected hydronephrosis. Pediatr Nephrol. 2005;20 :1253 –1259[CrossRef][Web of Science][Medline]
  48. Zhang PL, Peters CA, Rosen S. Ureteropelvic junction obstruction: morphological and clinical studies. Pediatr Nephrol. 2000;14 :820 –826[CrossRef][Web of Science][Medline]
  49. Ueno S, Suzuki Y, Murakami T, et al. Quantitative analysis of infantile ureteropelvic junction obstruction by diuretic renography. Ann Nucl Med. 2001;15 :131 –136[Web of Science][Medline]
  50. Karam M, Feustel PJ, Goldfarb CR, Kogan BA. Diuretic renogram clearance half-times in the diagnosis of obstructive uropathy: effect of age and previous surgery. Nucl Med Commun. 2003;24 :797 –807[CrossRef][Web of Science][Medline]
  51. Odibo AO, Raab E, Elovitz M, Merrill JD, Macones GA. Prenatal mild pyelectasis: evaluating the thresholds of renal pelvic diameter associated with normal postnatal renal function. J Ultrasound Med. 2004;23 :513 –517[Abstract/Free Full Text]
  52. Gloor JM, Ramsey PS, Ogburn PL, Jr, Danilenko-Dixon DR, DiMarco CS, Ramin KD. The association of isolated mild fetal hydronephrosis with postnatal vesicoureteral reflux. J Matern Fetal Neonatal Med. 2002;12 :196 –200[Medline]
  53. Phan V, Traubici J, Hershenfield B, Stephens D, Rosenblum ND, Geary DF. Vesicoureteral reflux in infants with isolated antenatal hydronephrosis. Pediatr Nephrol. 2003;18 :1224 –1228[CrossRef][Web of Science][Medline]
  54. Penido Silva JM, Oliveira EA, Diniz JS, Bouzada MC, Vergara RM, Souza BC. Clinical course of prenatally detected primary vesicoureteral reflux. Pediatr Nephrol. 2006;21 :86 –91[CrossRef][Web of Science][Medline]
  55. Ylinen E, Ala-Houhala M, Wikstrom S. Risk of renal scarring in vesicoureteral reflux detected either antenatally or during the neonatal period. Urology. 2003;61 :1238 –1243[CrossRef][Web of Science][Medline]
  56. Upadhyay J, McLorie GA, Bolduc S, Bagli DJ, Khoury AE, Farhat W. Natural history of neonatal reflux associated with prenatal hydronephrosis: long-term results of a prospective study. J Urol. 2003;169 :1837 –1841[CrossRef][Web of Science][Medline]
  57. Chowdhary SK, Walter S, Chaudhuri RK, Bhagat A, Joseph SC. Antenatal diagnosis of hydronephrosis: outcome with a conservative approach. Indian Pediatr. 2001;38 :1401 –1404[Medline]
  58. Morin L, Cendron M, Crombleholme TM, Garmel SH, Klauber GT, D'Alton ME. Minimal hydronephrosis in the fetus: clinical significance and implications for management. J Urol. 1996;155 :2047 –2049[CrossRef][Web of Science][Medline]
PEDIATRICS (ISSN 1098-4275). ©2006 by the American Academy of Pediatrics

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 CJASNHome page
D. K. Hothi, A. S. Wade, R. Gilbert, and P. J. D. Winyard
Mild Fetal Renal Pelvis Dilatation--Much Ado About Nothing?
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 168 - 177.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, R. S.
Right arrow Articles by Nguyen, H. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, R. S.
Right arrow Articles by Nguyen, H. T.
Related Collections
Right arrow Genitourinary Tract
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?